Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Bothersome blisters: localized epidermolysis bullosa simplex.

Hisaw L, Twu O, Rodriguez L, Holland V, Young L.

Cutis. 2019 Mar;103(3):E24-E26. No abstract available.

PMID:
31039243
2.

Non-pruritic bullous scabies in an immunosuppressed pediatric patient.

Salame N, Holland V.

Pediatr Dermatol. 2019 Jul;36(4):552-553. doi: 10.1111/pde.13797. Epub 2019 Apr 15.

PMID:
30989695
3.

A case of atezolizumab-induced photodistributed bullous pemphigoid.

Leavitt E, Holland V.

Dermatol Ther. 2019 Jul;32(4):e12924. doi: 10.1111/dth.12924. Epub 2019 Apr 25.

PMID:
30977954
4.

Consensus-based care recommendations for adults with myotonic dystrophy type 1.

Ashizawa T, Gagnon C, Groh WJ, Gutmann L, Johnson NE, Meola G, Moxley R 3rd, Pandya S, Rogers MT, Simpson E, Angeard N, Bassez G, Berggren KN, Bhakta D, Bozzali M, Broderick A, Byrne JLB, Campbell C, Cup E, Day JW, De Mattia E, Duboc D, Duong T, Eichinger K, Ekstrom AB, van Engelen B, Esparis B, Eymard B, Ferschl M, Gadalla SM, Gallais B, Goodglick T, Heatwole C, Hilbert J, Holland V, Kierkegaard M, Koopman WJ, Lane K, Maas D, Mankodi A, Mathews KD, Monckton DG, Moser D, Nazarian S, Nguyen L, Nopoulos P, Petty R, Phetteplace J, Puymirat J, Raman S, Richer L, Roma E, Sampson J, Sansone V, Schoser B, Sterling L, Statland J, Subramony SH, Tian C, Trujillo C, Tomaselli G, Turner C, Venance S, Verma A, White M, Winblad S.

Neurol Clin Pract. 2018 Dec;8(6):507-520. doi: 10.1212/CPJ.0000000000000531. Review.

5.

Ecthyma gangrenosum due to Pseudomonas fluorescens.

O'Leary RE, Holland V, Kulkarni RP.

Cutis. 2018 Jul;102(1):E13-E15. No abstract available.

PMID:
30138506
6.

Chilblain lupus erythematosus presenting with bilateral hemorrhagic bullae of distal halluces.

Aleshin M, Martin S, Palla B, Holland V, Young L.

Cutis. 2018 Jun;101(6):E16-E18. No abstract available.

PMID:
30063789
7.

Recovery of hair in the psoriatic plaques of a patient with coexistent alopecia universalis.

Anastasiou C, Goh C, Holland V.

Cutis. 2017 Apr;99(4):E9-E12. No abstract available.

PMID:
28492603
8.

Atypical laboratory presentation of paraneoplastic pemphigus associated with Castleman disease.

Lonowski S, Goldbach H, Holland V.

JAAD Case Rep. 2017 Mar 15;3(2):138-139. doi: 10.1016/j.jdcr.2017.01.016. eCollection 2017 Mar. No abstract available.

9.

A new species of Neoephemera McDunnough, 1925 (Ephemeroptera: Neoephemeridae) from North Carolina and Virginia.

Holland VB, Beaty SR, Jacobus LM.

Zootaxa. 2016 Jul 14;4138(1):139-54. doi: 10.11646/zootaxa.4138.1.6.

PMID:
27470756
10.

Taxonomic and ecological relevance of the chlorophyll a fluorescence signature of tree species in mixed European forests.

Pollastrini M, Holland V, Brüggemann W, Bruelheide H, Dănilă I, Jaroszewicz B, Valladares F, Bussotti F.

New Phytol. 2016 Oct;212(1):51-65. doi: 10.1111/nph.14026. Epub 2016 Jun 6.

11.

Extrication time prediction tool.

Nutbeam T, Fenwick R, Hobson C, Holland V, Palmer M.

Emerg Med J. 2015 May;32(5):401-3. doi: 10.1136/emermed-2013-202864. Epub 2014 Apr 17.

PMID:
24743587
12.

Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists.

Wilson DM, Apps J, Bailey N, Bamford MJ, Beresford IJ, Brackenborough K, Briggs MA, Brough S, Calver AR, Crook B, Davis RK, Davis RP, Davis S, Dean DK, Harris L, Heslop T, Holland V, Jeffrey P, Panchal TA, Parr CA, Quashie N, Schogger J, Sehmi SS, Stean TO, Steadman JG, Trail B, Wald J, Worby A, Takle AK, Witherington J, Medhurst AD.

Bioorg Med Chem Lett. 2013 Dec 15;23(24):6890-6. doi: 10.1016/j.bmcl.2013.09.090. Epub 2013 Oct 5.

PMID:
24269482
13.

Insight into the photosynthetic apparatus in evergreen and deciduous European oaks during autumn senescence using OJIP fluorescence transient analysis.

Holland V, Koller S, Brüggemann W.

Plant Biol (Stuttg). 2014 Jul;16(4):801-8. doi: 10.1111/plb.12105. Epub 2013 Sep 24.

PMID:
24112772
14.

The stages of extrication: a prospective study.

Nutbeam T, Fenwick R, Hobson C, Holland V, Palmer M.

Emerg Med J. 2014 Dec;31(12):1006-8. doi: 10.1136/emermed-2013-202668. Epub 2013 Sep 4.

PMID:
24005643
15.

Interactions and competition processes among tree species in young experimental mixed forests, assessed with chlorophyll fluorescence and leaf morphology.

Pollastrini M, Holland V, Brüggemann W, Koricheva J, Jussila I, Scherer-Lorenzen M, Berger S, Bussotti F.

Plant Biol (Stuttg). 2014 Mar;16(2):323-31. doi: 10.1111/plb.12068. Epub 2013 Aug 8.

PMID:
23926925
16.

Sweet's Syndrome Presenting in Concordance with Acute Coronary Syndrome.

Kassardjian M, Holland V, Leong T, Horowitz D, Hirokane J.

J Clin Aesthet Dermatol. 2012 Sep;5(9):47-50.

17.

Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor.

Carolan CG, Dillon GP, Khan D, Ryder SA, Gaynor JM, Reidy S, Marquez JF, Jones M, Holland V, Gilmer JF.

J Med Chem. 2010 Feb 11;53(3):1190-9. doi: 10.1021/jm9014845.

PMID:
20067290
18.

Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.

Jones M, Inkielewicz I, Medina C, Santos-Martinez MJ, Radomski A, Radomski MW, Lally MN, Moriarty LM, Gaynor J, Carolan CG, Khan D, O'Byrne P, Harmon S, Holland V, Clancy JM, Gilmer JF.

J Med Chem. 2009 Nov 12;52(21):6588-98. doi: 10.1021/jm900561s.

PMID:
19821574
19.

Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1.

Westaway SM, Thompson M, Rami HK, Stemp G, Trouw LS, Mitchell DJ, Seal JT, Medhurst SJ, Lappin SC, Biggs J, Wright J, Arpino S, Jerman JC, Cryan JE, Holland V, Winborn KY, Coleman T, Stevens AJ, Davis JB, Gunthorpe MJ.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5609-13. doi: 10.1016/j.bmcl.2008.08.105. Epub 2008 Aug 31.

PMID:
18809327
20.

Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.

Gunthorpe MJ, Hannan SL, Smart D, Jerman JC, Arpino S, Smith GD, Brough S, Wright J, Egerton J, Lappin SC, Holland VA, Winborn K, Thompson M, Rami HK, Randall A, Davis JB.

J Pharmacol Exp Ther. 2007 Jun;321(3):1183-92. Epub 2007 Mar 28.

PMID:
17392405
21.

N-Tetrahydroquinolinyl, N-quinolinyl and N-isoquinolinyl biaryl carboxamides as antagonists of TRPV1.

Westaway SM, Chung YK, Davis JB, Holland V, Jerman JC, Medhurst SJ, Rami HK, Stemp G, Stevens AJ, Thompson M, Winborn KY, Wright J.

Bioorg Med Chem Lett. 2006 Sep 1;16(17):4533-6. Epub 2006 Jun 27.

PMID:
16806913
22.

A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonists.

Goodacre CJ, Bromidge SM, Clapham D, King FD, Lovell PJ, Allen M, Campbell LP, Holland V, Riley GJ, Starr KR, Trail BK, Wood MD.

Bioorg Med Chem Lett. 2005 Nov 15;15(22):4989-93.

PMID:
16168649
23.

Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.

Ahmed M, Briggs MA, Bromidge SM, Buck T, Campbell L, Deeks NJ, Garner A, Gordon L, Hamprecht DW, Holland V, Johnson CN, Medhurst AD, Mitchell DJ, Moss SF, Powles J, Seal JT, Stean TO, Stemp G, Thompson M, Trail B, Upton N, Winborn K, Witty DR.

Bioorg Med Chem Lett. 2005 Nov 1;15(21):4867-71.

PMID:
16143522
24.

8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.

Heightman TD, Gaster LM, Pardoe SL, Pilleux JP, Hadley MS, Middlemiss DN, Price GW, Roberts C, Scott CM, Watson JM, Gordon LJ, Holland VA, Powles J, Riley GJ, Stean TO, Trail BK, Upton N, Austin NE, Ayrton AD, Coleman T, Cutler L.

Bioorg Med Chem Lett. 2005 Oct 1;15(19):4370-4.

PMID:
16039851
25.

Peroxyl radical mediated oxidative DNA base damage: implications for lipid peroxidation induced mutagenesis.

Lim P, Wuenschell GE, Holland V, Lee DH, Pfeifer GP, Rodriguez H, Termini J.

Biochemistry. 2004 Dec 14;43(49):15339-48.

PMID:
15581346
26.

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety.

Wood MD, Reavill C, Trail B, Wilson A, Stean T, Kennett GA, Lightowler S, Blackburn TP, Thomas D, Gager TL, Riley G, Holland V, Bromidge SM, Forbes IT, Middlemiss DN.

Neuropharmacology. 2001 Aug;41(2):186-99.

PMID:
11489455
27.

Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.

Duxon MS, Stretton J, Starr K, Jones DN, Holland V, Riley G, Jerman J, Brough S, Smart D, Johns A, Chan W, Porter RA, Upton N.

Psychopharmacology (Berl). 2001 Jan 1;153(2):203-9.

PMID:
11205420
28.

1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists.

Bromidge SM, Davies S, Duckworth DM, Forbes IT, Jones GE, Jones J, King FD, Blackburn TP, Holland V, Kennett GA, Lightowler S, Middlemiss DN, Riley GJ, Trail B, Wood MD.

Bioorg Med Chem Lett. 2000 Aug 21;10(16):1867-70.

PMID:
10969987
29.

1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolytic agents.

Bromidge SM, Dabbs S, Davies S, Duckworth DM, Forbes IT, Jones GE, Jones J, King FD, Saunders DV, Blackburn TP, Holland V, Kennett GA, Lightowler S, Middlemiss DN, Riley GJ, Trail B, Wood MD.

Bioorg Med Chem Lett. 2000 Aug 21;10(16):1863-6.

PMID:
10969986
30.

Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent.

Bromidge SM, Dabbs S, Davies DT, Davies S, Duckworth DM, Forbes IT, Gaster LM, Ham P, Jones GE, King FD, Mulholland KR, Saunders DV, Wyman PA, Blaney FE, Clarke SE, Blackburn TP, Holland V, Kennett GA, Lightowler S, Middlemiss DN, Trail B, Riley GJ, Wood MD.

J Med Chem. 2000 Mar 23;43(6):1123-34.

PMID:
10737744
31.

Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonists.

Bromidge SM, Dabbs S, Davies DT, Davies S, Duckworth DM, Forbes IT, Gadre A, Ham P, Jones GE, King FD, Saunders DV, Thewlis KM, Vyas D, Blackburn TP, Holland V, Kennett GA, Riley GJ, Wood MD.

Bioorg Med Chem. 1999 Dec;7(12):2767-73.

PMID:
10658582
32.

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.

Reavill C, Kettle A, Holland V, Riley G, Blackburn TP.

Br J Pharmacol. 1999 Feb;126(3):572-4.

33.

Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines.

Bromidge SM, Dabbs S, Davies DT, Duckworth DM, Forbes IT, Ham P, Jones GE, King FD, Saunders DV, Starr S, Thewlis KM, Wyman PA, Blaney FE, Naylor CB, Bailey F, Blackburn TP, Holland V, Kennett GA, Riley GJ, Wood MD.

J Med Chem. 1998 May 7;41(10):1598-612.

PMID:
9572885
34.

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.

Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP.

Neuropharmacology. 1997 Apr-May;36(4-5):609-20.

PMID:
9225286
35.

m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor.

Thomas DR, Gager TL, Holland V, Brown AM, Wood MD.

Neuroreport. 1996 Jun 17;7(9):1457-60.

PMID:
8856697
36.

Hepatitis B vaccine for medical students.

Wallin MT, McDiarmid M, Montopoli M, Presson A, Holland V.

JAMA. 1996 Feb 14;275(6):444. No abstract available.

PMID:
8627959
37.

Prevalence of antibodies to hepatitis B and C among fire department personnel prior to implementation of a hepatitis B vaccination program.

Porter ES, McDiarmid M, Montopoli M, Presson A, Holland V.

J Occup Environ Med. 1996 Feb;38(2):125-7; author reply 127-8. No abstract available.

PMID:
8673516
38.

N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B receptor antagonist.

Forbes IT, Jones GE, Murphy OE, Holland V, Baxter GS.

J Med Chem. 1995 Mar 17;38(6):855-7. No abstract available.

PMID:
7699699
39.

Transcellular and paracellular pathways in lingual epithelia and their influence in taste transduction.

Simon SA, Holland VF, Benos DJ, Zampighi GA.

Microsc Res Tech. 1993 Oct 15;26(3):196-208.

PMID:
8241559
40.

Ion transport across lingual epithelium is modulated by chorda tympani nerve fibers.

Simon SA, Elliott EJ, Erickson RP, Holland VF.

Brain Res. 1993 Jul 2;615(2):218-28.

PMID:
8364732
41.

Semiquantitative measurement of cytomegalovirus DNA in lung and heart-lung transplant patients by in vitro DNA amplification.

Cagle PT, Buffone G, Holland VA, Samo T, Demmler GJ, Noon GP, Lawrence EC.

Chest. 1992 Jan;101(1):93-6.

PMID:
1309500
42.

Differential perfusion: potential complication of femoral-femoral bypass during single lung transplantation.

Sekela ME, Noon GP, Holland VA, Lawrence EC.

J Heart Lung Transplant. 1991 Mar-Apr;10(2):322-4.

PMID:
2031932
43.

Lymphocyte subset populations in bronchiolitis obliterans after heart-lung transplantation.

Holland VA, Cagle PT, Windsor NT, Noon GP, Greenberg SD, Lawrence EC.

Transplantation. 1990 Dec;50(6):955-9.

PMID:
2124009
44.

Pulmonary function after heart-lung transplantation using larger donor organs.

Lloyd KS, Barnard P, Holland VA, Noon GP, Lawrence EC.

Am Rev Respir Dis. 1990 Nov;142(5):1026-9.

PMID:
2240823
45.

Transbronchial biopsy.

Cagle PT, Truong LD, Holland VA, Lawrence EC, Noon GP, Greenberg SD.

Transplantation. 1990 May;49(5):1025. No abstract available.

PMID:
2336696
46.

Lung transplantation for end-stage pulmonary disease. Effects of donor lung size on pulmonary function.

Lloyd KS, Barnard PA, Holland VA, Young JB, Noon P, Whisennand HH, DeBakey ME, Lawrence EC.

Chest. 1990 Mar;97(3 Suppl):110S. No abstract available.

PMID:
2306996
47.

Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantation.

Lawrence EC, Holland VA, Young JB, Windsor NT, Brousseau KP, Noon GP, Whisennand HH, Debakey ME, Nelson DL.

Am Rev Respir Dis. 1989 Sep;140(3):789-96.

PMID:
2506785
48.

Lung biopsy evaluation of acute rejection versus opportunistic infection in lung transplant patients.

Cagle PT, Truong LD, Holland VA, Lawrence EC, Noon GP, Greenberg SD.

Transplantation. 1989 Apr;47(4):713-5. No abstract available.

PMID:
2650047
49.

Factors contributing to mortality in lung transplant recipients: an autopsy study.

Cagle PT, Truong LD, Holland VA, Lawrence EC, Rogers BB, Schwartz MR, Kolda T, Buffone GJ, Noon GP, Greenberg SD.

Mod Pathol. 1989 Mar;2(2):85-9.

PMID:
2657722
50.

Supplemental Content

Loading ...
Support Center